ArticleAnnals of medicine and surgery (2012)2026
CRISPR-directed epigenetic reprogramming of the FLT1 locus: a novel strategy for reversing fetal hemoglobin silencing in β-thalassemia minor.
Maheen Naz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.